Miracle Mile Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.67M Sell
13,205
-1,642
-11% -$208K 0.03% 273
2025
Q1
$1.9M Sell
14,847
-6,628
-31% -$848K 0.04% 223
2024
Q4
$2.84M Buy
21,475
+4,782
+29% +$632K 0.06% 181
2024
Q3
$2.43M Sell
16,693
-964
-5% -$140K 0.06% 169
2024
Q2
$2.42M Sell
17,657
-7,197
-29% -$988K 0.06% 168
2024
Q1
$3.41M Buy
24,854
+308
+1% +$42.3K 0.09% 143
2023
Q4
$3.33M Sell
24,546
-300,787
-92% -$40.9M 0.09% 133
2023
Q3
$39.8M Buy
325,333
+1,399
+0.4% +$171K 1.23% 25
2023
Q2
$41.1M Buy
323,934
+20,653
+7% +$2.62M 1.25% 24
2023
Q1
$39.2M Buy
303,281
+12,095
+4% +$1.56M 1.27% 18
2022
Q4
$38.2M Buy
291,186
+257,089
+754% +$33.8M 1.31% 19
2022
Q3
$3.99M Buy
34,097
+7,790
+30% +$911K 0.19% 81
2022
Q2
$3.1M Buy
26,307
+17,572
+201% +$2.07M 0.15% 116
2022
Q1
$1.14M Buy
+8,735
New +$1.14M 0.05% 220
2020
Q3
Sell
-1,610
Closed -$220K 374
2020
Q2
$220K Buy
+1,610
New +$220K 0.02% 284
2019
Q2
Sell
-1,790
Closed -$200K 272
2019
Q1
$200K Buy
+1,790
New +$200K 0.02% 252